.
The Harvard Medical School International Center for Genetic Diseases (HMS-iCGD) and the UAE Genetics Diseases Association (UAEGDA) are collaborating on a pilot Research and Training Project. This initiative is fully aligned with the goals and aspirations of both organizations and is consistent with their strategies in advancing genomic medicine.
Advances in genomics, clinical diagnostic methods, and therapies are revolutionizing healthcare. By integrating clinical data with genetic information, healthcare providers can enhance population screening, diagnosis, prognosis, and risk management. In some cases, these advancements enable the development of innovative, targeted therapies for conditions such as cardiovascular diseases, lipid disorders, diabetes, cancer, and many other clinically complex morbidities.
